CPhI Istanbul Launches as Pharma's Gateway to the High-Growth Markets of Eurasia, Central Asia and MENA Regions

AsiaNet 54214

ISTANBUL, Sept. 10 /PRN=KYODO JBN/ -

           New event to act as regional confluence for 22 countries, with

Turkey's domestic demand alone forecast to reach $22.8billion by 2015

    UBM Live has today announced the latest addition to its global

pharmaceutical events portfolio, CPhI Istanbul 2014

[http://www.cphi-istanbul.com ]. CPhI is the leading pharmaceutical networking

event and will take place on June 4th-6th 2014 at the Lutfi Kirdar

International Convention and Exhibition Centre in Istanbul.

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    The Eurasian region is on the precipice of exponential pharmaceutical

sector growth, with Turkey as a core country within this region as growth is

forecast to reach $16bilion by 2014. With the event located in Istanbul, it

acts as a central melting pot for both the Turkish pharmaceutical sector, those

in Eurasia, Central Asia and MENA regions. There are also a significant number

of pharmaceutical companies operating in Istanbul, with exports

to neighbouring countries reflecting the highly regarded position Istanbul

holds within the market and it's potential to become a foremost provider of

pharmaceuticals.

    Istanbul is the ideal geographical hub in the region between some of the

world's most dynamic pharma markets- with Turkey being the OECDs fastest

growing economy. As the confluence between Asia, Europe and MENA, Istanbul

serves as a meeting point for trade, with the regional pharma market no

exception, and is seen as the go-to destination for pharmaceuticals. The

exhibitor profile reflects this diversity with 115 companies from key

countries including exhibitors from the region's largest healthcare economies

of Israel, Egypt, and Saudi Arabia.

    CPhI Istanbul 2014 will provide the first centralised event for regional

drug manufacturers to meet with global suppliers of raw materials, machinery,

packaging solutions and contract services, as well as attracting visitors from

the region looking for suppliers and manufacturing partners to bring

cost-competitive pharmaceuticals to their individual markets.

    The event has formed a strategic partnership with the Pharmaceutical

Manufacturers Association of Turkey (IEIS

[http://www.ieis.org.tr/asp_pages/index.asp ]), who are exclusively supporting

the event and providing active promotion amongst their members-

emphasising the status that CPhI Istanbul holds as the foremost trade fair for

presenting new business opportunities for pharmaceutical companies within the

region.

    What's more, 33 investment projects designed to develop new and modernise

existing pharmaceutical industries in the MENA and Central Asia region will

complete by 2015- with a total value of nearly $400m. This commitment to

creating reformed healthcare economies represents a tremendous growth

opportunity for private companies both local and international- especially for

higher-yield pharmaceutical products where demand is rising rapidly, which is

attracting the attention of multinational Pharma companies.

    Similarly, Turkey's pharmaceutical sector is currently ranked seventh in

Europe and 16th globally and the next few years are predicted to be a very

exciting time for investing, particularly as healthcare spending in the country

is predicted to rise over the next year. Furthermore, the Turkish government is

introducing financial incentives in an attempt to increase attraction from

international drug producing companies, and exports are estimated to rise to a

potential $8 billion.

    CPhI Istanbul, which will co-locate with P-MEC, InnoPack and ICSE, will

provide a new meeting point for bringing together senior pharma professionals

and international pharmaceutical suppliers and buyers of pharma raw materials,

machinery, packaging solutions and contract services. Collaboratively, it is

expected that the shows will attract around 2,000 visitors, both local and

international.

    Highlights of CPhI Istanbul 2014:

    - Co-location with P-MEC, InnoPack and ICSE providing services and

      opportunities through the whole supply chain

    - Conference programme, produced by UBM conferences featuring opinion

leaders from government, academia and industry with workshops, round tables and

plenary sessions

    - A buyers programme to deliver high-value buyers in growing markets

    - Invitation-only welcome reception and networking event

    - Potential one-to-one partnering for visitors and exhibitors to provide

new leads and business partners

    CPhI Istanbul 2014 will focus on pharma ingredients, with exhibiting

companies covering ingredients, APIs, fine chemicals, excipients,

biopharmaceuticals and more, whilst P-MEC will successfully deliver innovative

pharmaceutical equipment and technology to a worldwide forum of decision

makers. It is the must-attend networking event for any business in the

pharmaceutical machinery, equipment and technology industry. InnoPack will

also be taking place, which offers the pharma community innovative and diverse

packaging and drug delivery solutions to satisfy the changing way in which

medication is packaged and delivered. Connecting the pharmaceutical community

with outsourcing solution providers is ICSE, which provides a forum for

business development, networking and education.

    Chris Kilbee, Group Director, CPhI Pharma Portfolio, commented on the

launch of the event: "CPhI Istanbul will provide an unrivalled opportunity to

act as central business hub for the 22 countries within this region and help

stimulate growth in what is already a dynamic and readily reforming and

modernising healthcare and pharma market. With government support in the region

on the rise, alongside a rapidly changing healthcare landscape, the event

launch marks a new stage in positioning regional companies within a

more global context. CPhI Istanbul will bring together local Turkish drug

manufacturers with regional suppliers of raw materials and will undoubtedly

help to build and develop the region as a prime area for manufacturing both

locally and internationally."

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe

Frankfurt, Germany; CPhI and P-MEC India (03-05 December, 2013 at the Bombay

Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan

(9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014); CPhI,

P-MEC and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia);

CPhI, P-MEC, ISCE, InnoPack Istanbul (4-6 June 1014 in Istanbul) CPhI, P-MEC,

ICSE, InnoPack and BioPh China (26-28 June 2014 in Shaghai) and CPhI, ICSE and

BioPh South America (05-07 August, 2014 at the Expo Center Norte in Sao Paulo,

Brazil).

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia, Istanbul and South America

co-located with ICSE for contract services, P-MEC for machinery, equipment &

technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI

provides an online buyer & supplier directory at CPhI-Online.com and hosts a

global community with news and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    About UBM Live

    UBM Live connects people and creates opportunities for companies across

five continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis

    De Facto Communications

    T: +44-207-203-6745 / 6740

    E: a.heeley@defacto.com / t.jervis@defacto.com

SOURCE: UBM Live